APUSApimeds Pharmaceuticals US, Inc. · NYSE American (trading under APUS.LF pending regained compliance) · $2.96M mkt cap
Assessed Sep 1, 2026 · Reassessment
Is the float you're seeing correct?
689.5K
Reported float

Data-service feed, fetched today. The number TradingView and most screeners show.

Refreshing · re-grade queued

Trade off 689.5K shares. Our reconstruction for APUS is being refreshed.

Dilution risk7/10HIGH
CONFIDENCE: MEDIUM

Our float reconstruction is being refreshed; the reported float is 689.5K. 4 convertible notes and 2 reverse splits can add another 2,735% of the float. This company has cut its own floor prices before.

  • Preferred stock conversion overhang. 747,702 Series A Convertible Preferred shares convert 1:20 into 14,954,040 common — 26.6x the 563,192-share tradeable float and 9.9x the 1,509,118 shares outstanding.

  • Variable-rate convertible in default (death spiral). The $10,900,000 senior secured convertible note carries a conversion price 'subject to reset and other anti-dilution adjustments, with floor provisions dependent on future market price' — the company…

  • Lock-up / Rule 144 seasoning creating new free-trading supply. 251,520 shares (16.7% of outstanding, 44.7% of the current float) were issued to E.F.

From today's float to the ceiling

shares
563.2K
Estimated float
tradeable today
+0 can sell now
563.2K
Effective supply
float plus what sells on notice
+16.35M if floors are cut and warrants exercise
16.91M
Fully diluted
ceiling

Where the shares come from

each subtotal is a rung on the ladder above

Tradeable today
563.2K
Can sell now
Warrants in the money
None of the outstanding warrants are exercisable at this price.
+0
Effective supply
563.2K
Converts only if floors are cut
Notes with no conversion price set
Sized in dollars until a price or floor is set; not counted in the ceiling. Includes unfunded commitments, which are capacity rather than outstanding debt.
$126.40M
Preferred stock, as converted
Common equivalent at the stated conversion ratio.
+14.95M
Above the current price
Warrants out of the money
Struck above the current tape; supply only if the stock rises.
+111.7K
Options and RSUs
Employee equity; vests and settles over time.
+131.0K
Other, per engine ceiling
Included in the engine's fully-diluted count but not itemised in the filings we parsed.
+1.15M
Fully diluted
16.91M

Not counted anywhere: ATM and shelf capacity. Convertible share counts use stated conversion prices.

See the full breakdown

Red flags, financing counterparties, the deal timeline, and every SEC filing — free with an account.

Sign in to continue

The facts

Price
—
Market cap
$2.96M
Shares outstanding
1.85M
Reported float
689.5K
Avg volume
75.6K
Reverse splits
2 · latest 1-for-10 · Jul 24, 2026
Going concern
Yes · 0.07 quarters runway
Quarterly burn
$3.87M

Market data as of Nov 22, 2026

Key dates

  • Dec 8, 2026 · Senior secured convertible note ($10,900,000 redemption amount plus 18% default interest) matures
  • Dec 31, 2026 · Related-party notes ($500,100) mature

New to these numbers?

The full free course